TB-500 Peptide: A Research Deep-Dive into Thymosin Beta-4 Fragment Science and Laboratory Handling

For laboratory and research use only. The information below is provided strictly for educational and scientific reference. This compound is not intended for human consumption, diagnosis, or treatment.

TB-500 is one of the most frequently requested tissue-repair research peptides in the Philippine laboratory market, and one of the most frequently misunderstood. It is routinely described as "thymosin beta-4," which is not quite right: TB-500 is a short synthetic fragment of that much larger protein. That distinction matters for anyone reading the literature, comparing certificates of analysis, or deciding what a given vial actually contains. This guide covers the molecule, how it appears in published preclinical work, how it behaves in solution, and what researchers in the Philippines should check before ordering.

What TB-500 actually is

Thymosin beta-4 (Tβ4) is a 43-amino-acid actin-sequestering protein found in nearly every mammalian cell type and in high concentration in platelets and wound fluid. It is one of the most abundant intracellular proteins in the body, and its principal documented biochemical function is binding monomeric (G-) actin, regulating the pool available for filament assembly.

TB-500, the material supplied as a research peptide, is a synthetic fragment corresponding to the central actin-binding domain of Tβ4 — most commonly the seven-residue sequence LKKTETQ, sometimes supplied as a slightly longer flanking construct. It is this region that carries the actin-binding motif, which is why the fragment is studied as a lower-molecular-weight proxy for the full protein in cell-migration and repair models.

• Full protein: thymosin beta-4, 43 residues, approximately 4.9 kDa
• Research fragment: TB-500, typically the LKKTETQ actin-binding domain
• Supplied form: lyophilised (freeze-dried) acetate salt powder, white to off-white cake

A practical consequence: a vial labelled TB-500 and a vial labelled thymosin beta-4 are not interchangeable materials, and a certificate of analysis reporting a mass near 890 Da is describing the fragment, not the 4.9 kDa parent protein. Researchers comparing suppliers should read the mass-spectrometry figure, not only the product name. Our guide on how to read a peptide certificate of analysis walks through what those numbers mean.

How TB-500 appears in the published literature

Preclinical interest in thymosin beta-4 and its actin-binding fragment clusters around a few recurring experimental models:

• Cell migration assays. Because actin sequestration governs cytoskeletal remodelling, Tβ4 and its fragments are studied in keratinocyte, endothelial and fibroblast migration systems.
• Dermal and corneal repair models. Full-length Tβ4 has been examined in animal and ex vivo wound-closure work, including clinical-stage ophthalmic research on the parent protein.
• Cardiac and vascular models. Rodent-model work has examined Tβ4 in relation to epicardial progenitor cell migration and angiogenesis markers.
• Inflammation and fibrosis endpoints. Several studies report changes in inflammatory signalling markers in Tβ4-treated tissue preparations.

Two caveats are worth stating plainly for anyone designing a study. First, much of the strongest published work uses full-length Tβ4 rather than the LKKTETQ fragment, so findings do not transfer automatically between the two. Second, TB-500 is not an approved medicine in the Philippines or elsewhere, and it appears on the World Anti-Doping Agency prohibited list — relevant to institutional record-keeping for any laboratory handling it. Researchers sourcing the fragment for actin-dynamics work can review the TB-500 research peptide listing for available vial sizes.

Solubility, stability and laboratory handling

TB-500 is a small, highly hydrophilic peptide with several charged residues, which makes it one of the more straightforward research peptides to bring into solution. In practical laboratory terms:

• It dissolves readily in sterile water and in bacteriostatic water, without the acidification some hydrophobic sequences require. Bacteriostatic water is the usual laboratory solvent where a multi-draw working solution is being prepared; acetic water is reserved for sequences that will not go into a neutral solvent.
• Lyophilised powder is stable for extended periods when kept cool, dry and shielded from light; for storage beyond roughly three months, frozen storage at -20°C is standard laboratory practice.
• Once reconstituted, solutions are refrigerated at 2 to 8°C and protected from repeated freeze-thaw cycling, which is a leading cause of measurable loss of intact peptide on HPLC re-check.
• Philippine humidity is a real variable. A vial opened in an un-airconditioned room draws moisture into the cake, which both accelerates degradation and makes gravimetric assumptions unreliable. Our storage guide for Philippine conditions covers cold chain and humidity control in more detail.

TB-500 alongside other repair-model peptides

In the tissue-repair literature TB-500 rarely appears alone. It is most often studied next to, or in combination with, other compounds in the same experimental space:

• BPC-157 research peptide — a 15-residue gastric-juice-derived pentadecapeptide studied in overlapping tendon, ligament and gastrointestinal models, but through different proposed mechanisms (nitric-oxide pathway and angiogenesis signalling rather than actin sequestration).
• BPC-157 + TB-500 blend — a single-vial combination for study designs calling for both compounds at a fixed ratio.
• KLOW blend — GHK-Cu, BPC-157, TB-500 and KPV together; and GLOW blend — BPC-157, TB-500 and GHK-Cu.
• KPV research peptide — the alpha-MSH-derived tripeptide studied for inflammatory signalling endpoints.

Multi-compound vials introduce an analytical complication worth planning for: a blend's certificate of analysis should resolve each component separately, and a single purity figure for a four-peptide blend tells you very little. Request the per-component HPLC data before treating a blend as a quantified input. Researchers assembling a comparison set can browse the full range of research peptides to see what is currently stocked and what is available on request.

What to verify before ordering in the Philippines

The Philippine market has seen a visible increase in unverified peptide supply, and the FDA has issued advisories against specific unregistered compound products. For a research purchase, the checks that matter are documentary rather than cosmetic:

• An independently hosted certificate of analysis with a mass figure consistent with the fragment rather than the parent protein.
• A batch or lot number on the vial that matches the certificate.
• HPLC purity reported as a figure with a chromatogram, not as a claim such as "high purity".
• A supplier that will say plainly when a certificate is pending, rather than substituting a different batch's document.

Products are sold strictly for laboratory research and are not for human or animal consumption.